shows research ... sugar blood confirming inadequate millions leaves New

... the Netherlands, demonstrates suboptimal use of HbA1c approving in clinical practice in a wide range of countries, leaving millions of mortals in poor inside track of their brand 2 diabetes and at risk of spun out-term complications.